Justia Vermont Supreme Court Opinion Summaries

Plaintiff brought suit on behalf of her minor children and a proposed class of individuals who were exposed to polychlorinated biphenyls (PCBs) while attending or working at certain Vermont public schools. The complaint alleged that defendants, as successors to Old Monsanto, manufactured and sold PCBs from facilities outside Vermont to third-party manufacturers, who incorporated PCBs into products such as fluorescent light ballasts and caulk. These products were later used in Vermont schools, where PCBs subsequently leaked into the air, allegedly resulting in toxic exposure.In the United States District Court for the District of Vermont, defendants moved to dismiss the complaint, arguing that Vermont’s medical-monitoring statute only applied to releases of toxic substances directly from facilities located within Vermont, and did not apply retroactively to exposures or sales occurring prior to the statute’s enactment in 2022. The District Court certified two questions to the Vermont Supreme Court for interpretation of the statute.The Vermont Supreme Court reviewed the certified questions. The Court held, first, that the sale of a toxic substance from facilities outside Vermont, which was then incorporated into products that leaked PCBs into the air of Vermont schools, qualified as a “release” within the meaning of Vermont’s medical-monitoring statute. Second, the Court held that the statute does not provide a remedy to plaintiffs whose exposure occurred before the statute’s enactment, but it does allow claims against defendants who sold a toxic substance before enactment, if the plaintiff’s exposure occurred after July 1, 2022. The Court provided these answers in response to the certified questions and clarified the scope and retroactivity of the statute. View "Neddo, as Guardian & Next Friend to Z.N." on Justia Law

Defendants Michael Touchette and Centurion Healthcare brought an interlocutory appeal of a trial court's certification of a class of plaintiffs in a Vermont Rule 75 action. The certified class was comprised of people in the custody of the Vermont Department of Corrections (DOC), each of whom suffered from opioid-use disorder, and alleged defendants’ medication-assisted treatment (MAT) program did not meet prevailing medical standards of care as required by Vermont law. Defendants, the former Commissioner of the DOC and its contract healthcare provider, argued the trial court erred both in finding that plaintiff Patrick Mullinnex exhausted his administrative remedies before filing suit, and in adopting the vicarious-exhaustion doctrine favored by several federal circuits in order to conclude that Mullinnex’s grievances satisfied the exhaustion requirement on behalf of the entire class. Defendants also contended the trial court’s decision to certify the class was made in error because plaintiffs did not meet Rule 23’s numerosity, commonality, typicality, and adequacy-of- representation requirements. After review, the Vermont Supreme Court reversed, concluding that - even if the vicarious-exhaustion doctrine was appropriately applied in Vermont - it could not apply in this case because, on the record before the trial court, no member of the putative class succeeded in exhausting his administrative remedies. Because plaintiffs’ failure to exhaust left the courts without subject-matter jurisdiction, the Supreme Court did not reach defendants’ challenges to the merits of the class-certification decision. View "Mullinnex et al . v. Menard et al." on Justia Law